Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
OBJECTIVE: We wished to determine whether treatment of vertebral osteoporosis with human parathyroid peptide 1-34 (hPTH 1-34), given as a daily injection with supplementary treatment with hormone replacement therapy (HRT), increases cancellous bone area in the ilium by increasing the size of packets...
Main Authors: | Bradbeer, J, Arlot, M, Meunier, P, Reeve, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1992
|
Similar Items
-
Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
by: Reeve, J, et al.
Published: (1981) -
Iliac trabecular bone formation predicts radial trabecular bone density changes in type 1 osteoporosis.
by: Hesp, R, et al.
Published: (1991) -
Temporal variations in iliac trabecular bone formation in vertebral osteoporosis.
by: Arlot, M, et al.
Published: (1993) -
A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
by: Reeve, J, et al.
Published: (1986) -
hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
by: Reeve, J, et al.
Published: (1991)